Concord Hospital

Concord 2139

0 studies enrolling now · 6 studies all time

What they study most

Acute Kidney Injury, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Graft Versus Host Disease, Chronic Lymphocytic Leukemia, Colitis, Ulcerative, Colorectal Neoplasms, Crohn's Disease, DLBCL, Diffuse Large B-cell Lymphoma, FL, Follicular Lymphoma, High-grade B-cell Lymphoma (HGBCL)

Studies at this site

• A Long-term Extension Study of PCI-32765 (Ibrutinib) — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial) — Completed